BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 10902608)

  • 1. Poor correspondence between predicted and experimental binding of peptides to class I MHC molecules.
    Andersen MH; Tan L; Søndergaard I; Zeuthen J; Elliott T; Haurum JS
    Tissue Antigens; 2000 Jun; 55(6):519-31. PubMed ID: 10902608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient MHC class I-peptide binding is required but does not ensure MHC class I-restricted immunogenicity.
    Feltkamp MC; Vierboom MP; Kast WM; Melief CJ
    Mol Immunol; 1994 Dec; 31(18):1391-401. PubMed ID: 7823965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A combined prediction strategy increases identification of peptides bound with high affinity and stability to porcine MHC class I molecules SLA-1*04:01, SLA-2*04:01, and SLA-3*04:01.
    Pedersen LE; Rasmussen M; Harndahl M; Nielsen M; Buus S; Jungersen G
    Immunogenetics; 2016 Feb; 68(2):157-65. PubMed ID: 26572135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method.
    Nielsen M; Lundegaard C; Lund O
    BMC Bioinformatics; 2007 Jul; 8():238. PubMed ID: 17608956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward the prediction of class I and II mouse major histocompatibility complex-peptide-binding affinity: in silico bioinformatic step-by-step guide using quantitative structure-activity relationships.
    Hattotuwagama CK; Doytchinova IA; Flower DR
    Methods Mol Biol; 2007; 409():227-45. PubMed ID: 18450004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematically benchmarking peptide-MHC binding predictors: From synthetic to naturally processed epitopes.
    Zhao W; Sher X
    PLoS Comput Biol; 2018 Nov; 14(11):e1006457. PubMed ID: 30408041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An automated prediction of MHC class I-binding peptides based on positional scanning with peptide libraries.
    Udaka K; Wiesmüller KH; Kienle S; Jung G; Tamamura H; Yamagishi H; Okumura K; Walden P; Suto T; Kawasaki T
    Immunogenetics; 2000 Aug; 51(10):816-28. PubMed ID: 10970096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous presentation of a nascent antigenic epitope to CD8+ CTL is more efficient than exogenous presentation.
    Hahn YS; Hahn CS; Braciale TJ
    Immunol Cell Biol; 1996 Oct; 74(5):394-400. PubMed ID: 8912001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving the prediction of HLA class I-binding peptides using a supertype-based method.
    Wang S; Bai Z; Han J; Tian Y; Shang X; Wang L; Li J; Wu Y
    J Immunol Methods; 2014 Mar; 405():109-20. PubMed ID: 24508661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell responses to bluetongue virus are directed against multiple and identical CD4+ and CD8+ T cell epitopes from the VP7 core protein in mouse and sheep.
    Rojas JM; Rodríguez-Calvo T; Peña L; Sevilla N
    Vaccine; 2011 Sep; 29(40):6848-57. PubMed ID: 21807057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of binding specificities of bovine leucocyte class I molecules: impacts for rational epitope discovery.
    Hansen AM; Rasmussen M; Svitek N; Harndahl M; Golde WT; Barlow J; Nene V; Buus S; Nielsen M
    Immunogenetics; 2014 Dec; 66(12):705-18. PubMed ID: 25186069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of T-cell responses to peptides and lipopeptides with MHC class I binding motifs derived from the amino acid sequence of the 19-kDa lipoprotein of Mycobacterium tuberculosis.
    Fonseca DP; Joosten D; Snippe H; Verheul AF
    Mol Immunol; 2000 Jun; 37(8):413-22. PubMed ID: 11090876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Competition inhibition of cytotoxic T-lymphocyte (CTL) lysis, a more sensitive method to identify candidate CTL epitopes than induction of antibody-detected MHC class I stabilization.
    Feltkamp MC; Vierboom MP; Toes RE; Ossendorp F; ter Schegget J; Melief CJ; Kast WM
    Immunol Lett; 1995; 47(1-2):1-8. PubMed ID: 8537084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance Evaluation of MHC Class-I Binding Prediction Tools Based on an Experimentally Validated MHC-Peptide Binding Data Set.
    Bonsack M; Hoppe S; Winter J; Tichy D; Zeller C; Küpper MD; Schitter EC; Blatnik R; Riemer AB
    Cancer Immunol Res; 2019 May; 7(5):719-736. PubMed ID: 30902818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Class I MHC-peptide interaction: structural and functional aspects.
    Ruppert J; Kubo RT; Sidney J; Grey HM; Sette A
    Behring Inst Mitt; 1994 Jul; (94):48-60. PubMed ID: 7998914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of MHC class I binding peptides using profile motifs.
    Reche PA; Glutting JP; Reinherz EL
    Hum Immunol; 2002 Sep; 63(9):701-9. PubMed ID: 12175724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pattern search method for putative anchor residues in T cell epitopes.
    Hobohm U; Meyerhans A
    Eur J Immunol; 1993 Jun; 23(6):1271-6. PubMed ID: 7684684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presentation of a horse cytochrome c peptide by multiple H-2b class I major histocompatibility complex (MHC) molecules to C57BL/6- and bm1-derived cytotoxic T lymphocytes: presence of a single MHC anchor residue may confer efficient peptide-specific CTL recognition.
    Sheil JM; Schell TD; Shepherd SE; Klimo GF; Kioschos JM; Paterson Y
    Eur J Immunol; 1994 Sep; 24(9):2141-9. PubMed ID: 7522163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural Definition of Duck Major Histocompatibility Complex Class I Molecules That Might Explain Efficient Cytotoxic T Lymphocyte Immunity to Influenza A Virus.
    Wu Y; Wang J; Fan S; Chen R; Liu Y; Zhang J; Yuan H; Liang R; Zhang N; Xia C
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28490583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The canine MHC class Ia allele DLA-88*508:01 presents diverse self- and canine distemper virus-origin peptides of varying length that have a conserved binding motif.
    Ross P; Nemec PS; Kapatos A; Miller KR; Holmes JC; Suter SE; Buntzman AS; Soderblom EJ; Collins EJ; Hess PR
    Vet Immunol Immunopathol; 2018 Mar; 197():76-86. PubMed ID: 29475511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.